Generic Sweden AB Statistics
Total Valuation
STO:GENI has a market cap or net worth of SEK 462.79 million. The enterprise value is 404.56 million.
| Market Cap | 462.79M |
| Enterprise Value | 404.56M |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | May 16, 2025 |
Share Statistics
STO:GENI has 12.29 million shares outstanding. The number of shares has increased by 0.14% in one year.
| Current Share Class | 12.29M |
| Shares Outstanding | 12.29M |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 48.58% |
| Owned by Institutions (%) | 13.62% |
| Float | 5.23M |
Valuation Ratios
The trailing PE ratio is 14.94 and the forward PE ratio is 12.89.
| PE Ratio | 14.94 |
| Forward PE | 12.89 |
| PS Ratio | 2.50 |
| PB Ratio | 6.95 |
| P/TBV Ratio | 6.95 |
| P/FCF Ratio | 11.87 |
| P/OCF Ratio | 11.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.17, with an EV/FCF ratio of 10.38.
| EV / Earnings | 13.04 |
| EV / Sales | 2.19 |
| EV / EBITDA | 10.17 |
| EV / EBIT | 10.49 |
| EV / FCF | 10.38 |
Financial Position
The company has a current ratio of 2.98
| Current Ratio | 2.98 |
| Quick Ratio | 2.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 7,714.60 |
Financial Efficiency
Return on equity (ROE) is 50.96% and return on invested capital (ROIC) is 299.47%.
| Return on Equity (ROE) | 50.96% |
| Return on Assets (ROA) | 24.84% |
| Return on Invested Capital (ROIC) | 299.47% |
| Return on Capital Employed (ROCE) | 52.74% |
| Weighted Average Cost of Capital (WACC) | 8.14% |
| Revenue Per Employee | 8.40M |
| Profits Per Employee | 1.41M |
| Employee Count | 21 |
| Asset Turnover | 1.90 |
| Inventory Turnover | 270.13 |
Taxes
In the past 12 months, STO:GENI has paid 8.09 million in taxes.
| Income Tax | 8.09M |
| Effective Tax Rate | 20.68% |
Stock Price Statistics
The stock price has decreased by -37.87% in the last 52 weeks. The beta is 0.71, so STO:GENI's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -37.87% |
| 50-Day Moving Average | 45.08 |
| 200-Day Moving Average | 50.28 |
| Relative Strength Index (RSI) | 31.71 |
| Average Volume (20 Days) | 39,051 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:GENI had revenue of SEK 184.76 million and earned 31.04 million in profits. Earnings per share was 2.52.
| Revenue | 184.76M |
| Gross Profit | 50.23M |
| Operating Income | 38.57M |
| Pretax Income | 39.13M |
| Net Income | 31.04M |
| EBITDA | 39.76M |
| EBIT | 38.57M |
| Earnings Per Share (EPS) | 2.52 |
Balance Sheet
The company has 58.24 million in cash and n/a in debt, with a net cash position of 58.24 million or 4.74 per share.
| Cash & Cash Equivalents | 58.24M |
| Total Debt | n/a |
| Net Cash | 58.24M |
| Net Cash Per Share | 4.74 |
| Equity (Book Value) | 66.59M |
| Book Value Per Share | 5.42 |
| Working Capital | 63.38M |
Cash Flow
In the last 12 months, operating cash flow was 39.73 million and capital expenditures -742,000, giving a free cash flow of 38.98 million.
| Operating Cash Flow | 39.73M |
| Capital Expenditures | -742,000 |
| Free Cash Flow | 38.98M |
| FCF Per Share | 3.17 |
Margins
Gross margin is 27.19%, with operating and profit margins of 20.88% and 16.80%.
| Gross Margin | 27.19% |
| Operating Margin | 20.88% |
| Pretax Margin | 21.18% |
| Profit Margin | 16.80% |
| EBITDA Margin | 21.52% |
| EBIT Margin | 20.88% |
| FCF Margin | 21.10% |
Dividends & Yields
This stock pays an annual dividend of 1.75, which amounts to a dividend yield of 4.65%.
| Dividend Per Share | 1.75 |
| Dividend Yield | 4.65% |
| Dividend Growth (YoY) | 6.67% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 63.37% |
| Buyback Yield | -0.14% |
| Shareholder Yield | 4.51% |
| Earnings Yield | 6.71% |
| FCF Yield | 8.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STO:GENI has an Altman Z-Score of 14.73 and a Piotroski F-Score of 6.
| Altman Z-Score | 14.73 |
| Piotroski F-Score | 6 |